Adaptive Biotechnologies CORP Form 4 insider transactions
NASDAQ
Francis Lo, Chief People Officer of Adaptive Biotechnologies, reports the acquisition and disposal of company stock and stock options related to vesting RSUs and tax obligations.
NASDAQ
Sharon Benzeno, Chief Commercial Officer of Adaptive Biotechnologies, sold shares to cover tax withholding obligations related to RSU vesting.
NASDAQ
President Julie Rubinstein of Adaptive Biotechnologies Corp reports acquisition and disposition of common stock to cover tax obligations related to vesting RSUs.
NASDAQ
Form 4: Adaptive Biotechnologies Corp: Chief Scientific Officer Reports Changes in Beneficial Ownership
Harlan S Robins, Chief Scientific Officer of Adaptive Biotechnologies Corp, reports changes in beneficial ownership of common stock on March 4, 2024.
NASDAQ
Adaptive Biotechnologies' CFO, Tycho Peterson, reports the acquisition and disposition of company stock to cover tax obligations related to RSU vesting.
NASDAQ
Chad Robins, CEO and Chairman of Adaptive Biotechnologies, reports the acquisition and disposal of company stock to cover tax obligations related to RSU vesting.
NASDAQ
Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies, sold shares to cover tax obligations related to the vesting of Restricted Stock Units (RSUs) and acquired stock options.